MedTrace Logo

Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

NCT03552003 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-08-26

No results posted yet for this study

Summary

The aim of the study is to develop a prognostic index for elderly patients with newly diagnosed cHL starting from a prospective observational study of consecutive cases registered after the completion of the Comprehensive Geriatric Assessment (CGA)

Conditions

  • Classical Hodgkin Lymphoma

Interventions

OTHER

Treatment for clinical practise

Prospective data collection with the aim to to develop a prognostic index for elderly patients with newly diagnosed cHL

Sponsors & Collaborators

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Vittorio Ruggero Zilioli, MD · SC Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano - Italy

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-10
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03552003 on ClinicalTrials.gov